Godrej Agrovet Ltd Share Price – NSE /  BSE

FMCG, Small Cap

CDPL is one of the leading private dairy companies in southern India and its products are sold under the brand name ‘Godrej Jersey’. Its turnover was Rs 1,540.50 crore in FY24.

The rational for the acquisition is to convert CDPL into a wholly owned subsidiary by acquiring remaining 48.06% equity stake from the existing equity shareholders of CDPL, in order to consolidate the company’s position in CDPL.

Pre acquisition, the company held 58,81,508 shares (51.94%), whereas post acquisition, it will hold 1,13,24,700 equity shares (100%) in CDPL.

The said transaction is expected to be completed on or before 30 September 2025.

Meanwhile, the company’s board approved the appointment of and remuneration payable to Y. V. Sathish as head – manufacturing & supply chain excellence effective from March 24, 2025.

Y. V. Sathish brings nearly three decades of extensive experience across geographies and diverse cultures, having worked with renowned FMCG companies like GlaxoSmithKline and Hindustan Unilever.

Godrej Agrovet is an agri-business company in India that focuses on research and development to improve the productivity of Indian farmers. It offers a range of products and services to increase crop and livestock yields sustainably. The company is a leader in various sectors, including animal feed, crop protection, oil palm, dairy, poultry, and processed foods.

The company’s consolidated net profit jumped 21.4% to Rs 111.49 crore in Q3 FY25 as compared with Rs 91.84 crore in same quarter last year. Net sales increased 4.4% YoY to Rs 2,444.64 crore during the quarter ended 31st December 2024.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the appointment of Y. V. Sathish as “Head- Manufacturing & Supply Chain Excellence” of the company effective from 24 March 2025.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the acquisition of balance 48.06% equity stake in CreamlineDairy Products (CDPL), making CDPL a wholly owned subsidiary of the Company, upon completion of the said acquisition.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the appointment of Y. V. Sathish as “Head- Manufacturing & Supply Chain Excellence” of the company effective from 24 March 2025.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the acquisition of balance 48.06% equity stake in CreamlineDairy Products (CDPL), making CDPL a wholly owned subsidiary of the Company, upon completion of the said acquisition.

Powered by Capital Market - Live News

The board of Godrej Agrovet at its meeting held on 11 February 2025 has approved the appointment and remuneration of Sunil Kataria (DIN: 06863609) as the “Chief Executive Officer & Managing Director - Designate” of the Company for a period commencing from 05 May 2025 upto 31 August 2025 and subsequently after superannuation of Balram Singh Yadav, as “Chief Executive Officer & Managing Director”, for a term of 5 (Five) Years commencing from 01 September 2025 upto 31 August 2030, subject to the approval of the Shareholder

Powered by Capital Market - Live News

CDPL is one of the leading private dairy companies in southern India and its products are sold under the brand name ‘Godrej Jersey’. Its turnover was Rs 1,540.50 crore in FY24.

The rational for the acquisition is to convert CDPL into a wholly owned subsidiary by acquiring remaining 48.06% equity stake from the existing equity shareholders of CDPL, in order to consolidate the company’s position in CDPL.

Pre acquisition, the company held 58,81,508 shares (51.94%), whereas post acquisition, it will hold 1,13,24,700 equity shares (100%) in CDPL.

The said transaction is expected to be completed on or before 30 September 2025.

Meanwhile, the company’s board approved the appointment of and remuneration payable to Y. V. Sathish as head – manufacturing & supply chain excellence effective from March 24, 2025.

Y. V. Sathish brings nearly three decades of extensive experience across geographies and diverse cultures, having worked with renowned FMCG companies like GlaxoSmithKline and Hindustan Unilever.

Godrej Agrovet is an agri-business company in India that focuses on research and development to improve the productivity of Indian farmers. It offers a range of products and services to increase crop and livestock yields sustainably. The company is a leader in various sectors, including animal feed, crop protection, oil palm, dairy, poultry, and processed foods.

The company’s consolidated net profit jumped 21.4% to Rs 111.49 crore in Q3 FY25 as compared with Rs 91.84 crore in same quarter last year. Net sales increased 4.4% YoY to Rs 2,444.64 crore during the quarter ended 31st December 2024.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the appointment of Y. V. Sathish as “Head- Manufacturing & Supply Chain Excellence” of the company effective from 24 March 2025.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the acquisition of balance 48.06% equity stake in CreamlineDairy Products (CDPL), making CDPL a wholly owned subsidiary of the Company, upon completion of the said acquisition.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the appointment of Y. V. Sathish as “Head- Manufacturing & Supply Chain Excellence” of the company effective from 24 March 2025.

Powered by Capital Market - Live News

The Board of Godrej Agrovet at its meeting held on 11 March 2025 has approved the acquisition of balance 48.06% equity stake in CreamlineDairy Products (CDPL), making CDPL a wholly owned subsidiary of the Company, upon completion of the said acquisition.

Powered by Capital Market - Live News

The board of Godrej Agrovet at its meeting held on 11 February 2025 has approved the appointment and remuneration of Sunil Kataria (DIN: 06863609) as the “Chief Executive Officer & Managing Director - Designate” of the Company for a period commencing from 05 May 2025 upto 31 August 2025 and subsequently after superannuation of Balram Singh Yadav, as “Chief Executive Officer & Managing Director”, for a term of 5 (Five) Years commencing from 01 September 2025 upto 31 August 2030, subject to the approval of the Shareholder

Powered by Capital Market - Live News